164 related articles for article (PubMed ID: 12810846)
1. Fluorogenic substrate [Ala-Pro]2-cresyl violet but not Ala-Pro-rhodamine 110 is cleaved specifically by DPPIV activity: a study in living Jurkat cells and CD26/DPPIV-transfected Jurkat cells.
Boonacker E; Elferink S; Bardai A; Fleischer B; Van Noorden CJ
J Histochem Cytochem; 2003 Jul; 51(7):959-68. PubMed ID: 12810846
[TBL] [Abstract][Full Text] [Related]
2. Rapid assay to detect possible natural substrates of proteases in living cells.
Boonacker E; Elferink S; Bardai A; Wormmeester J; Van Noorden CJ
Biotechniques; 2003 Oct; 35(4):766-8, 770, 772 passim. PubMed ID: 14579742
[TBL] [Abstract][Full Text] [Related]
3. Ala-Pro-cresyl violet, a synthetic fluorogenic substrate for the analysis of kinetic parameters of dipeptidyl peptidase IV (CD26) in individual living rat hepatocytes.
Van Noorden CJ; Boonacker E; Bissell ER; Meijer AJ; van Marle J; Smith RE
Anal Biochem; 1997 Oct; 252(1):71-7. PubMed ID: 9324943
[TBL] [Abstract][Full Text] [Related]
4. CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry.
Boonacker EP; Wierenga EA; Smits HH; Van Noorden CJ
J Histochem Cytochem; 2002 Sep; 50(9):1169-77. PubMed ID: 12185194
[TBL] [Abstract][Full Text] [Related]
5. Detection of tripeptidyl peptidase I activity in living cells by fluorogenic substrates.
Steinfeld R; Fuhrmann JC; Gärtner J
J Histochem Cytochem; 2006 Sep; 54(9):991-6. PubMed ID: 16782851
[TBL] [Abstract][Full Text] [Related]
6. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
[TBL] [Abstract][Full Text] [Related]
7. The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.
Tanaka T; Kameoka J; Yaron A; Schlossman SF; Morimoto C
Proc Natl Acad Sci U S A; 1993 May; 90(10):4586-90. PubMed ID: 7685106
[TBL] [Abstract][Full Text] [Related]
8. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.
Morimoto C; Lord CI; Zhang C; Duke-Cohan JS; Letvin NL; Schlossman SF
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9960-4. PubMed ID: 7937926
[TBL] [Abstract][Full Text] [Related]
9. A new type of fluorogenic substrates for determination of cellular dipeptidyl peptidase IV (DP IV/CD26) activity.
Lorey S; Faust J; Bühling F; Ansorge S; Neubert K
Adv Exp Med Biol; 2000; 477():111-5. PubMed ID: 10849736
[TBL] [Abstract][Full Text] [Related]
10. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
Ruiz P; Zacharievich N; Shenkin M
Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
[TBL] [Abstract][Full Text] [Related]
11. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
[TBL] [Abstract][Full Text] [Related]
12. The multifunctional or moonlighting protein CD26/DPPIV.
Boonacker E; Van Noorden CJ
Eur J Cell Biol; 2003 Feb; 82(2):53-73. PubMed ID: 12647932
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
Durinx C; Lambeir AM; Bosmans E; Falmagne JB; Berghmans R; Haemers A; Scharpé S; De Meester I
Eur J Biochem; 2000 Sep; 267(17):5608-13. PubMed ID: 10951221
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
15. Transcellular proteolysis demonstrated by novel cell surface-associated substrates of dipeptidyl peptidase IV (CD26).
Lorey S; Faust J; Mrestani-Klaus C; Kähne T; Ansorge S; Neubert K; Bühling F
J Biol Chem; 2002 Sep; 277(36):33170-7. PubMed ID: 12095981
[TBL] [Abstract][Full Text] [Related]
16. Effect of CD26/dipeptidyl peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors.
Aytac U; Sato K; Yamochi T; Yamochi T; Ohnuma K; Mills GB; Morimoto C; Dang NH
Br J Cancer; 2003 Feb; 88(3):455-62. PubMed ID: 12569391
[TBL] [Abstract][Full Text] [Related]
17. DEVDase detection in intact apoptotic cells using the cell permeant fluorogenic substrate, (z-DEVD)2-cresyl violet.
Lee BW; Johnson GL; Hed SA; Darzynkiewicz Z; Talhouk JW; Mehrotra S
Biotechniques; 2003 Nov; 35(5):1080-5. PubMed ID: 14628683
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of a series of highly fluorogenic substrates for glutathione transferases, a general strategy.
Zhang J; Shibata A; Ito M; Shuto S; Ito Y; Mannervik B; Abe H; Morgenstern R
J Am Chem Soc; 2011 Sep; 133(35):14109-19. PubMed ID: 21786801
[TBL] [Abstract][Full Text] [Related]
19. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha.
Aertgeerts K; Levin I; Shi L; Snell GP; Jennings A; Prasad GS; Zhang Y; Kraus ML; Salakian S; Sridhar V; Wijnands R; Tennant MG
J Biol Chem; 2005 May; 280(20):19441-4. PubMed ID: 15809306
[TBL] [Abstract][Full Text] [Related]
20. DPPIV/CD26: a tumor suppressor or a marker of malignancy?
Beckenkamp A; Davies S; Willig JB; Buffon A
Tumour Biol; 2016 Jun; 37(6):7059-73. PubMed ID: 26943912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
